Albert P. Parker - Feb 15, 2023 Form 4 Insider Report for Zynerba Pharmaceuticals, Inc. (ZYNE)

Role
Chief Legal Officer
Signature
/s/ Albert P. Parker
Stock symbol
ZYNE
Transactions as of
Feb 15, 2023
Transactions value $
-$1,719
Form type
4
Date filed
2/17/2023, 03:21 PM
Previous filing
Feb 9, 2023
Next filing
Oct 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYNE Common Stock Sale -$1.72K -3.17K -1.38% $0.54 227K Feb 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents shares required to be sold by the Reporting Person to satisfy tax obligations and certain equity plan administrator fees in connection with the vesting of shares of restricted stock. This sale was mandated by the equity plan administrator and does not represent a discretionary trade by the Reporting Person.